GGrantIndex
Sort

64,565 grants matching drug discovery

Development of novel proteins synthesis inhibitors for MDR tuberculosis

$936,466
Richard Edward Lee · St. Jude Children'S Research Hospital · R01 · FY2013 · AI

Identifying and validating new antibiotic targets in cell wall synthesis pathways

$936,346
Thomas G Bernhardt · Harvard Medical School · R01 · FY2012 · AI

Integrated, Individualized, Intelligent Prescribing (I3P)

$936,331
Josh F. Peterson · Vanderbilt University Medical Center · U01 · FY2017 · HG

DEVELOPMENTAL FUNDS (Core 002)

$936,081
Henry Shelton Earp · Univ Of North Carolina Chapel Hill · P30 · FY2019 · CA

Translating novel cancer targets and mechanisms from the CTD^2 Network using molecular glues

$936,002
Stuart L Schreiber · Broad Institute, Inc. · U01 · FY2022 · CA

Novel Functions of Lung Macrophages and Fibroblasts in Pulmonary Inflammation and Fibrosis

$936,000
Marc L Peters-Golden · University Of Michigan At Ann Arbor · R35 · FY2023 · HL

Novel Functions of Lung Macrophages and Fibroblasts in Pulmonary Inflammation and Fibrosis

$936,000
Marc L Peters-Golden · University Of Michigan At Ann Arbor · R35 · FY2025 · HL

An Innovative Approach to Identify Correctors of Metabolic Complications in HIV

$935,900
Pietro P Sanna · Scripps Research Institute, The · R01 · FY2024 · DK

Mechanisms of Oncogene Action in Tumorigenesis

$935,665
Frederic J. Kaye · Clinical Sciences · Z01 · FY2007 · CA

Targeting a Novel Regulator of Brain Aging and Alzheimer's Disease

$935,613
Bruce A Yankner · Harvard Medical School · R01 · FY2014 · AG

DNA Topoisomerases as nuclear and mitochondrial targets of Anticancer Drugs

$935,600
Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Project 1: Resistance caused by AR pathway reactivation

$935,583
Charles L Sawyers · Sloan-Kettering Inst Can Research · U54 · FY2017 · CA

Design and Study of New Nicotinic Analogs for Use in Depression

$935,567
Alan P. Kozikowski · University Of Illinois At Chicago · U19 · FY2010 · MH

Assay Development and High Throughput Screening Core

$935,553
Zhong-Yin Zhang · Indiana University Indianapolis · U54 · FY2022 · AG

Genetic Studies of Alzheimer Disease in Koreans

$935,432
Lindsay A. Farrer · Boston University Medical Campus · U01 · FY2022 · AG

Efforts to Discover Novel Therapies and Reduce Treatment Toxicities for Lymphoma and Chronic Lymphocytic Leukemia Patients Through Collaboration and the NCTN

$935,075
Boyu Hu · Utah State Higher Education System--University Of Utah · R50 · FY2025 · CA

Genetic Discovery and Application in a Clinical Setting Continuing a Partnership

$935,039
Eric B Larson · Kaiser Foundation Health Plan Of Washington · U01 · FY2013 · HG

Algorithm and genome-wide database of functional siRNAs

$934,752
Alex Chenchik · Cellecta, Inc. · R44 · FY2009 · HG

Next Generation Specificity Screening for Biotherapeutics using an Extracellular Proteome Array

$934,299
Benjamin Jacob Doranz · Integral Molecular · R44 · FY2020 · GM

Novel PK/PD Strategies for Polymyxin Combinations against Gram-negative Superbugs

$934,289
Brian Tsuji · State University Of New York At Buffalo · R01 · FY2018 · AI

Data Generation Core - Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells

$934,287
Leslie Michels Thompson · University Of California-Irvine · U54 · FY2018 · NS

Data Generation Core - Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells

$934,286
Leslie Michels Thompson · University Of California-Irvine · U54 · FY2015 · NS

Data Generation Core - Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells

$934,285
Leslie Michels Thompson · University Of California-Irvine · U54 · FY2016 · NS

The Physiology of Store-Operated Channels in the Nervous System

$934,240
Murali Prakriya · Northwestern University At Chicago · R35 · FY2024 · NS

Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)

$933,971
David S Stephens · Emory University · UM1 · FY2021 · AI